Tesamorelin Therapy for Metabolic & Body-Composition Support

Prescription peptide therapy clinically shown to support healthy IGF-1 levels and reduce visceral abdominal fat — under medical supervision.

Prescription-only • Physician reviewed • U.S. pharmacy dispensed
Start a Medical Evaluation

Tesamorelin Therapy for Visceral Fat & Lean Muscle Support
No obligation • Online assessment • Not a weight-loss drug

Compliance Credibility Bar

  • Clinically evaluated peptide
  • Physician-guided care
  • FDA-regulated pharmacies
  • Transparent pricing

What Is Tesamorelin?

Tesamorelin is a prescription peptide that works by stimulating the body’s natural growth hormone pathway. In clinical studies, it has been shown to increase IGF-1 levels and reduce visceral adipose tissue in certain adult populations, while helping support lean body mass.

Use is determined by a licensed healthcare provider based on medical eligibility.

See If You Qualify

How Tesamorelin Is Studied to Support Health

Visceral Fat Support

Studied for its role in reducing deep abdominal fat associated with metabolic risk.

Lean Mass Support

valuated for helping preserve lean body mass during lifestyle changes.

IGF-1 Activity

Shown in studies to support healthy IGF-1 levels.

Metabolic Balance

May support overall metabolic health under medical supervision.

Understanding Different GH-Related Therapies

Growth-hormone–related therapies differ in how they work and how they’re regulated. This comparison is for educational purposes only.

Tesamorelin Vs Sermorelin & HGH Injections

Why Choose Tesamorelin? Natural growth hormone (GH) levels decline about 1-2% per year after age 30.

Tesamorelin is a clinically validated peptide shown in studies to increase IGF-1 levels and reduce visceral adipose tissue (VAT) in adults with excess abdominal fat.

It’s been evaluated for its ability to support lean body mass and metabolic balance-under medical supervision. Tesamorelin is our Strongest Growth Hormone Stimulating Peptide!

Tesamorelin Benefits:

  • Clinically Proven Peptide Therapy
  • Shown in Studies to Raise IGF-1 by up to 65%
Feature Tesamorelin Sermorelin HGH Injections
How it Works Stimulates GH + IGF-1 for metabolic support Solid GH support Direct hormone
Safety Clinically proven Safe High risk
Efficacy Fat loss + muscle retention Fat Loss & Muscle Water retention
Regulation Rx, U.S. Licensed Pharmacy Rx only Controlled
Cost Moderate, high ROI Moderate Very expensive
Best For Body recomposition support GH support Short-term bulk

Treatment selection is determined by a licensed provider.

  • Prescription-only peptide therapy
  • Prescription-only peptide therapy
  • Physician-reviewed treatment plans
  • U.S.-licensed pharmacy dispensing
Start now

How Body Forward Works

Get Started in a Few Simple Steps

Step 1

Online Medical Intake

Complete a secure questionnaire about your health history, lifestyle, and goals—entirely online and on your schedule.

Step 2

Telehealth Provider Consultation

Consult with one of our licensed U.S. healthcare providers online. Your provider will review your intake, answer questions, and determine whether treatment options may be appropriate.

Care from home—without in-person appointments or waiting rooms

Step 3

Personalized Care Plan & Prescription

If approved, your provider creates a personalized care plan. Your prescription is processed, and medication is discreetly shipped directly to your door.

Treatment Overview

Tesamorelin is provided as a prescription injectable peptide. Usage instructions, dosing, and duration are determined by your prescribing provider.
  • Prescription medication
  • Injection supplies included
  • Discreet delivery
  • Pharmacy-compounded

FAQs (Meta-Friendly Answers)

Get Started Today
A: No. Tesamorelin is not approved as a weight-loss medication. It has been studied for visceral fat reduction and metabolic support under medical supervision.

A: Individual experiences vary. Some patients report noticing changes in areas like sleep quality, recovery, or overall energy within the first few weeks of consistent use.

Changes related to body composition, such as waist measurements or fat distribution, typically take longer and may become noticeable around 8–12 weeks when Tesamorelin is used as prescribed and combined with healthy lifestyle habits. In clinical studies, measurable reductions in visceral fat were observed over this timeframe under supervised conditions.

Results are not guaranteed and depend on individual factors, adherence, and medical guidance.

A: Tesamorelin has been evaluated in clinical research and is generally well tolerated when prescribed and monitored by a licensed provider.
A: Tesamorelin is taken once daily as a small, nearly painless injection just under the skin, usually in the evening. It’s administered in the abdomen using a fine, insulin-style needle and is designed for easy at-home use.Medication is shipped pre-mixed from a licensed pharmacy and arrives cold-packed, with no mixing required. Always follow your pharmacy’s instructions.

Clinically Guided Peptide Therapy — Without the Guesswork

Complete a free online assessment to see if Tesamorelin may be appropriate for you.

Get Started Today
No guarantees • Results vary • Prescription required
This site is for informational purposes only and does not provide medical advice. Tesamorelin is a prescription medication available only after evaluation by a licensed healthcare provider. Individual results vary. Not approved for weight loss.

Supporting Studies

Chapman IM et al. JCEM. 2005; 90(12): 6791–6800. – Dose-dependent IGF-1 increase (~48–65%) in healthy adults. PubMed

FDA Clinical Pharmacology Review – Tesamorelin (Egrifta®). 2010. AccessData.FDA.gov

Falutz J et al. N Engl J Med. 2007; 357(23): 2359–70. – Reduced visceral fat, increased IGF-1 in HIV-associated lipodystrophy. PubMed

Stanley TL et al. JAMA. 2014; 312(4): 380–389. – Visceral and liver fat reduction with Tesamorelin. JAMA Network

Falutz J et al. JCEM. 2010; 95(9): 4291–4304.-Phase 3 pooled analysis confirming efficacy and safety. Oxford Academic